Clinical trial
Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial…
NCT00084370 · University of Alabama at Birmingham, Other · Withdrawn
Key facts
| NCT number | NCT00084370 |
|---|---|
| Title | Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy |
| Official title | Molecular Alterations in Human Ovarian Epithelium Induced by Chemopreventive Agents in Patients at Elevated Inherited Risk of Ovarian Cancer: A Controlled Pilot Study in Ovarian Cancer Chemoprevention |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | brca1 Mutation Carrier, brca2 Mutation Carrier, Ovarian Cancer |
| Intervention type | Drug, Procedure |
| Interventions | celecoxib, oophorectomy |
| Enrollment | 0 |
| Start date | Jun 1, 2002 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2005 |
| First posted | Jun 11, 2004 |
| Last update posted | Aug 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: